Literature DB >> 2832481

Reactivity of cytomegalovirus structural polypeptides with different subclasses of IgG present in human serum.

M P Landini1, B Baldassarri, G Mirolo, A Ripalti, M La Placa.   

Abstract

Human cytomegalovirus (CMV) has at least 15 structural polypeptides which are immunogenic during natural infection. In this report we used immunoblotting to study the reactivity of each polypeptide with the four IgG subclasses present in CMV antibody-positive human serum obtained from both convalescent patients and from patients with serological evidence of active CMV infection. The results showed that in the serum of patients reactivity to several CMV polypeptides is mostly due to all four IgG subclasses, with IgG3 being the most prevalent followed by IgG1. Intermediate molecular weight polypeptides (namely p66, p61, p55, p49, p38) appear to be the major antigens responsible for the preferential induction of the IgG3 response. During convalescence the reactivity of all four IgG subclasses is evident only against a structural polypeptide of 150 kD molecular weight (MW), while intermediate MW polypeptides show variable IgG subclass reactivity. The presence of IgG3 to one or more polypeptides of intermediate MW might be of diagnostic interest.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832481     DOI: 10.1016/s0163-4453(88)93997-7

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  IgG subclass-specific antibodies to human cytomegalovirus (HCMV)-induced early antigens.

Authors:  A Hamann; H W Doerr
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals.

Authors:  P J Converse; T E Fehniger; A Ehrnst; O Strannegård; S Britton
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Antibody reactivity to cytomegalovirus structural polypeptides in subclinical and clinical human immunodeficiency virus infections.

Authors:  M P Landini; G Mirolo; M C Re; A Ripalti; M La Placa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

Review 4.  Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.

Authors:  B Weber; W Braun; J Cinatl; H W Doerr
Journal:  Clin Investig       Date:  1993-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.